Literature DB >> 9348670

Cell biology of autoimmune diseases.

J M Van Noort1, S Amor.   

Abstract

Autoimmune diseases such as insulin-dependent diabetes mellitus, rheumatoid arthritis, and multiple sclerosis are common in the western world and are often devastating diseases which pose serious health problems. The key feature of such diseases is the development and persistence of inflammatory processes in the apparent absence of pathogens, leading to chronic breakdown of selected tissues. To date, no comprehensive explanation can be given for the onset or persistence of autoimmunity. As a rule, the chronic activation of helper T lymphocytes reactive against self proteins appears to be crucial for fueling the destructive autoimmune process, but why this occurs remains to be established. In this review, we present an overview on the rules that govern activation of T lymphocytes and on the factors that control it. The contribution of both genetic and environmental factors are discussed, clarifying that most autoimmune disease are of multifactorial origin. Special emphasis is given to the contribution of infectious events and the role of stress proteins in the process. In attempts to dissect the mechanisms involved in autoimmunity and to develop ways of blocking disease, experimental animal models are widely employed. We describe the various experimental models that exist for the study of multiple sclerosis, diabetes, and other autoimmune diseases and on the experience that has been gained in such models with experimental therapies to block the activation of self-reactive T lymphocytes. The lessons that can be drawn from these studies provide hope that continued efforts will lead to the successful development of antigen-specific strategies which block the development of autoimmunity also in humans.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9348670     DOI: 10.1016/s0074-7696(08)62137-3

Source DB:  PubMed          Journal:  Int Rev Cytol        ISSN: 0074-7696


  5 in total

1.  Physiological matrix metalloproteinase concentrations in serum during childhood and adolescence, using Luminex Multiplex technology.

Authors:  Kathryn M Thrailkill; Cindy S Moreau; Gael Cockrell; Pippa Simpson; Rajiv Goel; Paula North; John L Fowlkes; Robert C Bunn
Journal:  Clin Chem Lab Med       Date:  2005       Impact factor: 3.694

2.  RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy.

Authors:  Shlomo Nedvetzki; Erez Gonen; Nathalie Assayag; Reuven Reich; Richard O Williams; Robin L Thurmond; Jing-Feng Huang; Birgit A Neudecker; Fu-Sheng Wang; Fu-Shang Wang; Eva A Turley; David Naor
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-13       Impact factor: 11.205

3.  Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody.

Authors:  L Weiss; S Slavin; S Reich; P Cohen; S Shuster; R Stern; E Kaganovsky; E Okon; A M Rubinstein; D Naor
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

4.  Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: a possible link between inflammatory cytokines and atherogenesis.

Authors:  M L Wong; B Xie; N Beatini; P Phu; S Marathe; A Johns; P W Gold; E Hirsch; K J Williams; J Licinio; I Tabas
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

Review 5.  Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy.

Authors:  Kathryn M Thrailkill; R Clay Bunn; John L Fowlkes
Journal:  Endocrine       Date:  2008-10-30       Impact factor: 3.633

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.